Orphan Drugs: A Growing Opportunity for Health Systems

Orphan Drug Strategies to Help 340B Health Systems Achieve More

Read time: 8 minutes

By: McKesson Health Systems Editorial Team

Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and diseases, but also for notoriously high costs that are rewriting the rules for pricing, discounts, and reimbursement.

In this eBook, we’ve curated key drivers, trends, and statistics to help health systems put today’s orphan drug issues into perspective.

Download the eBook to learn how McKesson can help you achieve more for your business of pharmacy.

Subscribe to our monthly Prescribed Perspectives newsletter to have our exclusive content delivered directly to your inbox!